Ching‐Lung Lai

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

Shiv Kumar Sarin, Manoj Kumar, George Lau et al. · Hepatology International · 2015 · 2.6K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

A One-Year Trial of Lamivudine for Chronic Hepatitis B

Ching‐Lung Lai, Rong‐Nan Chien, Nancy W.Y. Leung et al. · New England Journal of Medicine · 1998 · 1.8K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

Ching‐Lung Lai, Daniel Shouval, Anna S. Lok et al. · New England Journal of Medicine · 2006 · 1.2K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

Jordan J. Feld, Ira M. Jacobson, Christophe Hézode et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B†,‡

Ting‐Tsung Chang, Yun‐Fan Liaw, Shun-Sheng Wu et al. · Hepatology · 2010 · 988 citations · Full text

Medicine, Pathology, Pharmacotherapy +17